Medtronic InSync II Protect
This article was originally published in The Gray Sheet
Executive Summary
Resynchronization defibrillator (CRT), set to launch in Europe this quarter, is among cardiac rhythm management devices previewed during a Feb. 12 earnings call. InSync Protect "will offer unique programming efficiencies and tailored ICD therapy that leverages new clinical findings to minimize unnecessary shocks," CEO Art Collins claims. Medtronic has four CRT-D devices in the pipeline, beginning with InSync Maximo, scheduled for U.S. release this year (1"The Gray Sheet" Jan. 19, 2004, p. 5). Also set for domestic launch this year are six new ICD models, including the Intrinsic "core ICD," and two pacemaker platforms - EnPulse 2 by summer and EnRhythm by year-end...